Export file:


  • RIS(for EndNote,Reference Manager,ProCite)
  • BibTex
  • Text


  • Citation Only
  • Citation and Abstract

Modelling chemistry and biology after implantation of a drug-eluting stent. Part Ⅱ: Cell proliferation

1. College of Engineering, Mathematics, and Physical Sciences, University of Exeter, Exeter, Devon, EX4 4QF, United Kingdom
2. Department of Mathematics, University of Portsmouth, Winston Churchill Ave, Portsmouth PO1 2UP, United Kingdom
3. Mathematics Applications Consortium for Science and Industry, University of Limerick, Castletroy, Co. Limerick, Ireland

The aim of a drug eluting stent is to prevent restenosis of arteries following percutaneous balloon angioplasty. A long term goal of research in this area is to use modelling to optimise the design of these stents to maximise their efficiency. A key obstacle to implementing this is the lack of a mathematical model of the biology of restenosis. Here we investigate whether mathematical models of cancer biology can be adapted to model the biology of restenosis and the effect of drug elution. We show that relatively simple, rate kinetic models give a good description of available data of restenosis in animal experiments, and its modification by drug elution.

  Article Metrics

Keywords Drug-eluting stents; drug delivery; cell proliferation; mathematical modelling; parameter estimation

Citation: Adam Peddle, William Lee, Tuoi Vo. Modelling chemistry and biology after implantation of a drug-eluting stent. Part Ⅱ: Cell proliferation. Mathematical Biosciences and Engineering, 2018, 15(5): 1117-1135. doi: 10.3934/mbe.2018050


  • [1] World Health Organisation, Global Status Report on Noncommunicable Diseases 2010, Report of the World Health Organisation, 2011. Available from: http://www.who.int/nmh/publications/ncd_report_full_en.pdf.
  • [2] A. Bertuzzi, A. Fasano, A. Gandolfi and C. Sinisgalli, Tumour cords and their response to anticancer agents, in Modelling and Simulation in Science, Engineering, and Technology (ed. N. Bellomo), Birkhauser, (2008), 183–206.
  • [3] F. Bozsak,J. M. Chomaz,A. I. Barakat, Modeling the transport of drugs eluted from stents: Physical phenomena driving drug distribution in the arterial wall, Biomechanics and Modeling in Mechanobiology, 13 (2014): 327-347.
  • [4] F. Bozsak,D. Gonzalez-Rodriguez,Z. Sternberger,P. Belitz,T. Bewley,J. M. Chomaz,A. I. Barakat, Optimization of drug delivery by drug-eluting stents, PLoS One, 10 (2015): e0130182.
  • [5] A. Caiazzo,D. Evans,J.-L. Falcone,J. Hegewald,E. Lorenz,B. Stahl,D. Wang,J. Bernsdorf,B. Chopard,J. Gunn,R. Hose,M. Krafczyk,P. Lawford,R. Smallwood,D. Walker,A. Hoekstra, A Complex Automata approach for in-stent restenosis: Two-dimensional multiscale modelling and simulations, Journal of Computational Science, 2 (2011): 9-17.
  • [6] Y. S. Chatzizisis,A. U. Coskun,M. Jonas,E. R. Edelman,C. L. Feldman,P. H. Stone, Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior, Journal of the American College of Cardiology, 49 (2007): 2379-2393.
  • [7] D. E. Drachman,E. R. Edelman,P. Seifert,A. R. Groothuis,D. A. Bornstein,K. R. Kamath,M. Palasis,D. Yang,S. H. Nott,C. Rogers, Neointimal thickening after stent delivery of paclitaxel: Change in composition and arrest of growth over six months, Journal of the American College of Cardiology, 36 (2000): 2325-2332.
  • [8] J. A. Ferreira,J. Naghipoor,P. de Oliveira, Analytical and numerical study of a coupled cardiovascular drug delivery model, Journal of Computational and Applied Mathematics, 275 (2015): 433-446.
  • [9] F. J. H. Gijsen,F. Migliavacca,S. Schievano,L. Socci,L. Petrini,A. Thury,J. J. Wentzel,A. F. W. van der Steen,P. W. S. Serruys,G. Dubini, Simulation of stent deployment in a realistic human coronary artery, BioMedical Engineering OnLine, 7 (2008): 1-23.
  • [10] W. Khan,S. Farah,A. Nyska,A. J. Domb, Carrier free rapamycin loaded drug eluting stent: In vitro and in vivo evaluation, Journal of Controlled Release, 168 (2013): 70-76.
  • [11] W. Khan,S. Farah,A. J. Domb, Drug eluting stents: developments and current status, Journal of Controlled Release, 161 (2012): 703-712.
  • [12] B. M. Mazzag,J. S. Tamaresis,A. I. Barakat, A model for shear stress sensing and transduction in vascular endothelial cells, Biophysical Journal, 84 (2003): 4087-4101.
  • [13] S. McGinty,S. McKee,R. Wadsworth,C. McCormick, Modeling arterial wall drug concentrations following the insertion of a drug-eluting stent, SIAM Journal on Applied Mathematics, 73 (2013): 2004-2028.
  • [14] S. McGinty,T. T. N. Vo,M. Meere,S. McKee,C. McCormick, Some design considerations for polymer-free drug-eluting stents: A mathematical approach, Acta Biomaterialia, 18 (2015): 213-225.
  • [15] S. McGinty,M. Wheel,S. McKee,C. McCormick, Does anisotropy promote spatial uniformity of stent-delivered drug distribution in arterial tissue?, International Journal of Heat and Mass Transfer, 90 (2015): 266-279.
  • [16] J. C. Panetta, A mathematical model of breast and ovarian cancer treated with paclitaxel, Mathematical Biosciences, 146 (1997): 89-113.
  • [17] S. Pant,N. W. Bressloff,A. I. Forrester,N. Curzen, The influence of strut-connectors in stented vessels: A comparison of pulsatile flow through five coronary stents, Annals of Biomedical Engineering, 38 (2010): 1893-1907.
  • [18] G. Pontrelli,F. de Monte, Modelling of mass convection-diffusion in stent-based drug delivery, XXV Congresso Nazionale UIT sulla Trasmissione del Calore, null (2007).
  • [19] H. Tahir,I. Niculescu,C. Bona-Casas,R. M. H. Merks,A. G. Hoekstra, An in silico study on the role of smooth muscle cell migration in neointimal formation after coronary stenting, Journal of the Royal Society Interface, 12 (2015): 20150358.
  • [20] A. R. Tzafriri,A. Groothuis,G. S. Price,E. R. Edelman, Stent elution rate determines drug deposition and receptor-mediated effects, Journal of Controlled Release, 161 (2012): 918-926.
  • [21] T. T. N. Vo,A. Peddle,W. Lee, Modelling chemistry and biology after implantation of a drug-eluting stent. Part Ⅰ: Drug transport, Mathematical Biosciences and Engineering, 14 (2017): 491-509.
  • [22] T. T. N. Vo,R. Yang,Y. Rochev,M. Meere, A mathematical model for drug delivery, Progress in Industrial Mathematics at ECMI 2010, Mathematics in Industry, 17 (2012): 521-528.
  • [23] J. Watt,S. Kennedy,C. McCormick,E. O. Agbani,A. McPhaden,A. Mullen,P. Czudaj,B. Behnisch,R. M. Wadsworth,K. G. Oldroyd, Soccinobucal-eluting stents increase neointimal thickening and peri-strut inflammation in a porcine coronary model, Catheterization and Cardiovascular Interventions, 81 (2013): 698-708.
  • [24] T. K. Yeung,C. Germond,X. Chen,Z. Wang, The mode of action of taxol: Apoptosis at low concentration and necrosis at high concentration, Biochemical and Biophysical Research Communications, 263 (1999): 398-404.
  • [25] P. Zunino,C. D'Angelo,L. Petrini,C. Vergara,C. Capelli,F. Migliavacca, Numerical simulation of drug eluting coronary stents: Mechanics, fluid dynamics, and drug release, Computer Methods in Applied Mechanics and Engineering, 198 (2009): 3633-3644.


Reader Comments

your name: *   your email: *  

© 2018 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution Licese (http://creativecommons.org/licenses/by/4.0)

Download full text in PDF

Export Citation

Copyright © AIMS Press All Rights Reserved